HYPOGONADISM
Clinical trials for HYPOGONADISM explained in plain language.
Never miss a new study
Get alerted when new HYPOGONADISM trials appear
Sign up with your email to follow new studies for HYPOGONADISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a testosterone shot before surgery speed recovery?
Disease control OngoingThis early-phase trial is testing whether giving testosterone replacement therapy to men with low testosterone before and after major urologic surgery is safe and might improve recovery. Researchers will track quality of life, frailty, complications, hospital stay length, and rea…
Matched conditions: HYPOGONADISM
Phase: PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Testosterone drug JATENZO under safety spotlight for adrenal impact
Disease control OngoingThis Phase 4 study is checking whether JATENZO, a testosterone replacement drug, affects adrenal gland function in men with low testosterone (hypogonadism). About 110 men aged 18-65 will take JATENZO for 12 months. Researchers will measure cortisol levels after a stimulation test…
Matched conditions: HYPOGONADISM
Phase: PHASE4 • Sponsor: Tolmar Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:07 UTC
-
Super MRI scans peek inside brains of testicular cancer survivors
Knowledge-focused TerminatedThis study uses a very powerful 7 Tesla MRI scanner to take detailed pictures of the brain in testicular cancer patients who have low testosterone (hypogonadism) and are on testosterone replacement therapy. The goal is to see if the MRI can detect changes in brain structure and f…
Matched conditions: HYPOGONADISM
Sponsor: University of Southern California • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC